PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
2B70.DE vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


2B70.DESPY
YTD Return14.75%27.04%
1Y Return31.27%39.75%
3Y Return (Ann)2.58%10.21%
5Y Return (Ann)8.13%15.93%
Sharpe Ratio1.873.15
Sortino Ratio2.764.19
Omega Ratio1.331.59
Calmar Ratio1.234.60
Martin Ratio8.5720.85
Ulcer Index3.59%1.85%
Daily Std Dev16.66%12.29%
Max Drawdown-30.87%-55.19%
Current Drawdown-0.23%0.00%

Correlation

-0.50.00.51.00.4

The correlation between 2B70.DE and SPY is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

2B70.DE vs. SPY - Performance Comparison

In the year-to-date period, 2B70.DE achieves a 14.75% return, which is significantly lower than SPY's 27.04% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


40.00%60.00%80.00%100.00%120.00%140.00%160.00%JuneJulyAugustSeptemberOctoberNovember
52.10%
158.35%
2B70.DE
SPY

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


2B70.DE vs. SPY - Expense Ratio Comparison

2B70.DE has a 0.35% expense ratio, which is higher than SPY's 0.09% expense ratio.


2B70.DE
iShares Nasdaq US Biotechnology UCITS ETF
Expense ratio chart for 2B70.DE: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%
Expense ratio chart for SPY: current value at 0.09% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.09%

Risk-Adjusted Performance

2B70.DE vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


2B70.DE
Sharpe ratio
The chart of Sharpe ratio for 2B70.DE, currently valued at 1.77, compared to the broader market-2.000.002.004.006.001.77
Sortino ratio
The chart of Sortino ratio for 2B70.DE, currently valued at 2.70, compared to the broader market-2.000.002.004.006.008.0010.0012.002.70
Omega ratio
The chart of Omega ratio for 2B70.DE, currently valued at 1.31, compared to the broader market1.001.502.002.503.001.31
Calmar ratio
The chart of Calmar ratio for 2B70.DE, currently valued at 0.99, compared to the broader market0.005.0010.0015.000.99
Martin ratio
The chart of Martin ratio for 2B70.DE, currently valued at 7.87, compared to the broader market0.0020.0040.0060.0080.00100.00120.007.87
SPY
Sharpe ratio
The chart of Sharpe ratio for SPY, currently valued at 2.87, compared to the broader market-2.000.002.004.006.002.87
Sortino ratio
The chart of Sortino ratio for SPY, currently valued at 3.82, compared to the broader market-2.000.002.004.006.008.0010.0012.003.82
Omega ratio
The chart of Omega ratio for SPY, currently valued at 1.54, compared to the broader market1.001.502.002.503.001.54
Calmar ratio
The chart of Calmar ratio for SPY, currently valued at 4.10, compared to the broader market0.005.0010.0015.004.10
Martin ratio
The chart of Martin ratio for SPY, currently valued at 18.60, compared to the broader market0.0020.0040.0060.0080.00100.00120.0018.60

2B70.DE vs. SPY - Sharpe Ratio Comparison

The current 2B70.DE Sharpe Ratio is 1.87, which is lower than the SPY Sharpe Ratio of 3.15. The chart below compares the historical Sharpe Ratios of 2B70.DE and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
1.77
2.87
2B70.DE
SPY

Dividends

2B70.DE vs. SPY - Dividend Comparison

2B70.DE has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.17%.


TTM20232022202120202019201820172016201520142013
2B70.DE
iShares Nasdaq US Biotechnology UCITS ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.17%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%1.81%

Drawdowns

2B70.DE vs. SPY - Drawdown Comparison

The maximum 2B70.DE drawdown since its inception was -30.87%, smaller than the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and SPY. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-9.37%
0
2B70.DE
SPY

Volatility

2B70.DE vs. SPY - Volatility Comparison

iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and SPDR S&P 500 ETF (SPY) have volatilities of 3.90% and 3.95%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%JuneJulyAugustSeptemberOctoberNovember
3.90%
3.95%
2B70.DE
SPY